Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCORE
2005-000258-64Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of quetiapine in schizophrenia (2 arms), sponsored by AstraZeneca. Primary endpoints: Change in social functioning and Change in Strauss-Carpenter scale from baseline to last visit. Started Feb 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2005-000258-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000258-64.